Track the ARGOS THERAPEUTICS INC stock price and the full management transaction log of the company, a listed equity based in United States. Shares are listed on the US market, under the supervision of SEC (Form 4). Market capitalisation: €4.4bn. The latest transaction was disclosed on 12 January 2016 (Attribution). Among the most active insiders: Abbey Jeffrey D. The full history is free.
6
Insider Decl.
n/a
Thresholds
n/a
1 ops.
Buy Volume
n/a
n/a
Sell Volume
Fundamental score
Ranked 1,703 of 29,024 companies
77.9
score / 100
Value
99
Quality
57
FCF yld·
Earn yld·
EV/EBITDA1.8x
ROE4.6%
Gross mgn27%
Net mgn49%
Debt/EBITDA1.8x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
ARGOS THERAPEUTICS INC is a biopharmaceutical company focused on developing immunotherapies for the treatment of cancer and other diseases. It is listed on NASDAQ under the ticker ARGS.